PHR (PHR) insider plans Rule 144 sale of 426 common shares on NYSE in December 2025
Rhea-AI Filing Summary
A holder of PHR common stock has filed a Rule 144 notice to sell 426 shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $6,922.50. The sale is expected to occur around 12/17/2025, and the disclosure notes that there were 60,287,003 common shares outstanding.
The shares to be sold were acquired on 10/13/2025 via restricted stock vesting from the issuer as compensation. Over the prior three months, the seller, Yvonne Hui, reported selling 302 common shares on 10/15/2025 for gross proceeds of $6,960.50. By signing the notice, the seller represents that they are not aware of any material adverse information about the issuer that has not been publicly disclosed.
Positive
- None.
Negative
- None.
FAQ
What does the PHR Form 144 filing disclose?
The Form 144 discloses that a holder of PHR common stock plans to sell 426 shares on the NYSE under Rule 144, with an aggregate market value of $6,922.50.
How many PHR shares are being sold and when is the sale planned?
The holder plans to sell 426 common shares, with an approximate sale date of 12/17/2025, as disclosed in the Rule 144 notice.
How were the PHR shares to be sold acquired?
The 426 PHR common shares were acquired on 10/13/2025 through restricted stock vesting from the issuer as compensation.
What prior PHR stock sales by the same holder are disclosed?
The notice reports that Yvonne Hui sold 302 PHR common shares on 10/15/2025, generating gross proceeds of $6,960.50 in the past three months.
How many PHR shares were outstanding at the time of the planned sale?
The disclosure states that there were 60,287,003 PHR common shares outstanding at the time referenced in the notice.
What representation does the seller make in the PHR Form 144?
By signing, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.